Profil

JANDRAIN Bernard

Département de médecine interne > Service de diabétologie, nutrition, maladies métaboliques

See author's contact details
Main Referenced Co-authors
Scheen, André  (42)
Lefèbvre, Pierre  (16)
Paquot, Nicolas  (14)
Ernest, Philippe  (8)
Pirnay, Freddy  (7)
Main Referenced Keywords
Humans (24); Adult (11); Blood Glucose/metabolism (8); Male (8); C-Peptide/blood (7);
Main Referenced Disciplines
Endocrinology, metabolism & nutrition (35)
Pharmacy, pharmacology & toxicology (8)
Laboratory medicine & medical technology (3)
Human health sciences: Multidisciplinary, general & others (3)
Dentistry & oral medicine (1)

Publications (total 44)

The most downloaded
12735 downloads
Radermecker, R., Philips, J.-C., Jandrain, B., Paquot, N., Lefebvre, P., & Scheen, A. (2008). Le cerveau, un organe gluco-dependant. Effets deleteres de l'hypoglycemie et de l'hyperglycemie. Revue Médicale de Liège, 63 (5-6), 280-6. https://hdl.handle.net/2268/4211

The most cited

41 citations (Scopus®)

Jandrain, B., Pallikarakis, N., Normand, S., Pirnay, F., Lacroix, M., Mosora, F., Pachiaudi, C., Gautier, J. F., Scheen, A., & Riou, J. P. (1993). Fructose utilization during exercise in men: rapid conversion of ingested fructose to circulating glucose. Journal of Applied Physiology, 74 (5), 2146-54. doi:10.1152/jappl.1993.74.5.2146 https://hdl.handle.net/2268/14019

De Niet, S., Coffiner, M., Da Silva, S., JANDRAIN, B., Souberbielle, J.-C., & Cavalier, E. (2018). A randomized study to compare a monthly to a daily administration of vitamin D3 supplementation. Nutrients, 10 (6). doi:10.3390/nu10060659
Peer Reviewed verified by ORBi

Scheen, A., Ernest, P., & Jandrain, B. (2017). Protection cardio-renale par les inhibiteurs des SGLT2 (gliflozines) : d'EMPA-REG OUTCOME a CANVAS. Revue Médicale Suisse, 13 (571), 1421-1426.
Peer Reviewed verified by ORBi

Scheen, A., ERNEST, P., & JANDRAIN, B. (2017). La complémentarité entre essais cliniques contrôlés et registres observationnels : L'exemple des études de prévention cardiovasculaire avec les inhibiteurs des SGLT2. Revue Médicale de Liège, 72 (12), 563-568.
Peer reviewed

Scheen, A., WALLEMACQ, C., Jandrain, B., & Ernest, P. (2016). Protection cardiovasculaire du patient diabetique de type 2 : d'EMPA-REG OUTCOME a LEADER. Revue Médicale Suisse, 12 (527), 1370-1375.
Peer Reviewed verified by ORBi

SCHLECK, M.-L., Souberbielle, J.-C., JANDRAIN, B., Da Silva, S., De Niet, S., Vanderbist, F., SCHEEN, A., & CAVALIER, E. (2015). A Randomized, Double-Blind, Parallel Study to Evaluate the Dose-Response of Three Different Vitamin D Treatment Schemes on the 25-Hydroxyvitamin D Serum Concentration in Patients with Vitamin D Deficiency. Nutrients, 7, 5413-22. doi:10.3390/nu7075227
Peer Reviewed verified by ORBi

Ernest, P., Jandrain, B., & Scheen, A. (2015). Forces et faiblesse des essais cliniques . Evolution en fonction de l'essor de la medecine personnalisee. Revue Médicale de Liège, 70 (5-6), 232-6.
Peer reviewed

CAVALIER, E., JANDRAIN, B., Da Silva, S., De Niet, S., Vanderbist, F., & SCHEEN, A. (April 2014). A randomized, double-blinded, parallel study to evaluate the dose-response of a monthly supplementation of 25000, 50000 or 100000 IU of vitamin D3 in subjects with deficiency in vitamin D [Poster presentation]. Vitamin D and human health: from the gamete to the grave, Londres, United Kingdom.

SCHEEN, A., ERNEST, P., & JANDRAIN, B. (November 2012). Comment j’explore …Une différence de risque de survenue d’un événement dans les études cliniques. Revue Médicale de Liège, 67 (11), 597-602.
Peer reviewed

SCHEEN, A., RADERMECKER, R., ERNEST, P., & JANDRAIN, B. (31 August 2011). Inhibiteurs du cotransporteur du glucose SGLT rénal pour traiter le diabète de type 2. Revue Médicale Suisse, 7 (306), 1621-1629.
Peer Reviewed verified by ORBi

SCHEEN, A., Radermecker, R., Ernest, P., & Jandrain, B. (2011). Inhibiteurs du cotransporteur du glucose SGLT2 renal pour traiter le diabete de type 2. Revue Médicale Suisse, 7 (306), 1621-4, 1626-9.
Peer Reviewed verified by ORBi

Jandrain, B., Ernest, P., Radermecker, R., & Scheen, A. (2010). Strategies pour eviter l'inertie et la non-observance dans les essais cliniques. Revue Médicale de Liège, 65 (5-6), 246-9.
Peer reviewed

De Flines, J., Radermecker, R., Jandrain, B., & Scheen, A. (2009). Optimisation du traitement pharmacologique chez un patient avec un diabete de type 2 nouvellement diagnostique. Revue Médicale de Liège, 64 (2), 109-14.
Peer reviewed

Radermecker, R., Philips, J.-C., Jandrain, B., Paquot, N., & Scheen, A. (July 2008). L'etude clinique du mois. Controle glycemique et morbimortalite cardio-vasculaire chez le patient diabetique de type 2. Resultats des etudes ACCORD, ADVANCE et VA-Diabetes. Revue Médicale de Liège, 63 (7-8), 511-8.
Peer reviewed

Radermecker, R., Philips, J.-C., Jandrain, B., Paquot, N., Lefebvre, P., & Scheen, A. (2008). Le cerveau, un organe gluco-dependant. Effets deleteres de l'hypoglycemie et de l'hyperglycemie. Revue Médicale de Liège, 63 (5-6), 280-6.
Peer reviewed

Radermecker, R., Jandrain, B., Paquot, N., Philips, J.-C., Contessi, E., Lavigne, M., Rinaldi, A.-M., & Scheen, A. (2003). Prevention des hypoglycemies chez le patient diabetique de type 1. Revue Médicale de Liège, 58 (6), 361-8.
Peer reviewed

Magis, D., Jandrain, B., & Scheen, A. (2003). Alcool, sensibilite a l'insuline et diabete sucre. Revue Médicale de Liège, 58 (7-8), 501-7.
Peer reviewed

Scheen, A., Paquot, N., & Jandrain, B. (2002). Comment j'explore ... Le risque d'un patient d'evoluer vers un diabete de type 2. Revue Médicale de Liège, 57 (2), 113-5.
Peer reviewed

Scheen, A., Letiexhe, M., Geronooz, I., Paquot, N., & Jandrain, B. (2002). L'hyperglycemie post-prandiale. II. Approches therapeutiques medicamenteuses. Revue Médicale de Liège, 57 (4), 196-201.
Peer reviewed

Scheen, A., Paquot, N., Jandrain, B., & Lefebvre, P. (2002). L'hyperglycemie post-prandiale. I. Physiopathologie, consequences cliniques et approaches dietetiques. Revue Médicale de Liège, 57 (3), 138-41.
Peer reviewed

SCHEEN, A., PAQUOT, N., LETIEXHE, M., & JANDRAIN, B. (2002). Approches pharmacologiques de prévention du diabète de type 2. Médecine et Hygiène, 60, 1480-1484.
Peer Reviewed verified by ORBi

SCHEEN, A., JANDRAIN, B., PAQUOT, N., LETIEXHE, M., & Lefebvre, P. (2001). Contrôle pharmacologique de l’hyperglycémie postprandiale. Médecine et Hygiène, 59, 1619-1624.
Peer Reviewed verified by ORBi

Scheen, A., Rorive, M., Letiexhe, M., Devoitille, L., & Jandrain, B. (2001). Un sujet obese par une approche multidisciplinaire: l'exemple du Centre de l'Obesite du CHU Ourthe-Ambleve. Revue Médicale de Liège, 56 (7), 474-9.
Peer reviewed

Scheen, A., & Jandrain, B. (2001). Adaptations hormono-metaboliques a l'exercice musculaire. Revue Médicale de Liège, 56 (4), 195-9.
Peer reviewed

Scheen, A., Philips, J.-C., Luyckx, F., Paquot, N., & Jandrain, B. (2001). Comment j'explore ... les differentes formes de diabete sucre: diagnostic differentiel clinique et biologique. Revue Médicale de Liège, 56 (9), 650-5.
Peer reviewed

Jandrain, B., & Scheen, A. (2001). Pratique de l'exercice musculaire chez le patient diabetique. Revue Médicale de Liège, 56 (5), 300-5.
Peer reviewed

Gautier, J. F., Pirnay, F., Jandrain, B., Lacroix, M., Mosora, F., Scheen, A., Cathelineau, G., & Lefebvre, P. (1994). Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade. European Journal of Applied Physiology and Occupational Physiology, 68 (5), 406-12. doi:10.1007/BF00843737
Peer Reviewed verified by ORBi

Castillo, M. J., Scheen, A., Jandrain, B., & Lefebvre, P. (1994). Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity. International Journal of Obesity, 18 (1), 47-53.
Peer Reviewed verified by ORBi

Scheen, A., Jandrain, B., Humblet, D., Jaminet, C. B., Gaspard, U., & Lefebvre, P. (1993). Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism. Fertility and Sterility, 59 (4), 797-802. doi:10.1016/s0015-0282(16)55862-2
Peer Reviewed verified by ORBi

Gautier, J. F., Pirnay, F., Jandrain, B., Lacroix, M., Mosora, F., Scheen, A., & Lefebvre, P. (1993). Endogenous substrate oxidation during exercise and variations in breath 13CO2/12CO2. Journal of Applied Physiology, 74 (1), 133-8. doi:10.1152/jappl.1993.74.1.133
Peer Reviewed verified by ORBi

Jandrain, B., Pallikarakis, N., Normand, S., Pirnay, F., Lacroix, M., Mosora, F., Pachiaudi, C., Gautier, J. F., Scheen, A., & Riou, J. P. (1993). Fructose utilization during exercise in men: rapid conversion of ingested fructose to circulating glucose. Journal of Applied Physiology, 74 (5), 2146-54. doi:10.1152/jappl.1993.74.5.2146
Peer Reviewed verified by ORBi

Scheen, A., Paolisso, G., Castillo, M., JANDRAIN, B., Paquot, N., & Lefebvre, P. (1992). Insulin secretion and action in various populations with type 2 (non-insulin-dependant) diabetes mellitus. Diabetologia, 16 ( suppl 1) (29), 116.
Peer Reviewed verified by ORBi

Scheen, A., GUIOT, J., Stassen, M. P., Jandrain, B., Paquot, N., & Lefebvre, P. J. (April 1991). Transfert des insulines U40 aux insulines U100: comparaison des profils insulinémiques et glycémiques chez le patient diabétique. Revue Médicale de Liège, 46 (4), 181-7.
Peer reviewed

Scheen, A., Guiot, J., JANDRAIN, B., Stassen, M. P., PAQUOT, N., & Lefebvre, P. (1991). Transfert des insulines U40 aux insulines U100: comparaison des profils insulinémiques et glycémiques chez des patients diabétiques de type 1 et de type 2 traités par insuline Monotard HM et Actrapid HM matin et soir. Diabetes and Metabolism, 17 (suppl), 31.
Peer Reviewed verified by ORBi

Jandrain, B., Lefèbvre, P., Pirnay, F., & Scheen, A. (1990). Alimentation avant, pendant et après l'exercice physique chez le sujet normal et diabétique. Journées Annuelles de Diabetologie de l'Hôtel-Dieu, 159-70.

Jandrain, B., Humblet, D., Jaminet, C. B., Scheen, A., Gaspard, U., & Lefebvre, P. (1990). Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial. American Journal of Obstetrics and Gynecology, 163 (1 Pt 2), 378-81. doi:10.1016/0002-9378(90)90586-V
Peer Reviewed verified by ORBi

Scheen, A., Gillet, J., Rosenthaler, J., Guiot, J., Henrivaux, P., Jandrain, B., & Lefebvre, P. (1989). Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients. Diabetologia, 32 (11), 801-9. doi:10.1007/BF00264911
Peer Reviewed verified by ORBi

Jandrain, B., Pirnay, F., Lacroix, M., Mosora, F., Scheen, A., & Lefebvre, P. (1989). Effect of osmolality on availability of glucose ingested during prolonged exercise in humans. Journal of Applied Physiology, 67 (1), 76-82. doi:10.1152/jappl.1989.67.1.76
Peer Reviewed verified by ORBi

Jandrain, B., Pirnay, F., Scheen, A., & Lefebvre, P. (1988). Adaptations au sport du diabetique traite par insuline. Diabète et Métabolisme, 14 (2), 127-35.
Peer Reviewed verified by ORBi

SCHEEN, A., Henrivaux, P., SCHEEN, M., JANDRAIN, B., PAQUOT, N., & Lefebvre, P. (1988). Les cures de jeûne modifié, protidique ou glucido-protidique, dans le traitement de l'obésité morbide. Médecine et Nutrition, 24, 157-164.
Peer Reviewed verified by ORBi

PAQUOT, N., Henrivaux, Scheen, A., JANDRAIN, B., & LEFEBVRE, P. (03 April 1987). Changes in plasma and erythrocyte magnesium concentrations during protein- sparing modified fast (PSMF) in obese subjects: comparison Alburone versus Nutroclin VLC [Poster presentation]. Symposium "Magnesium in daily practice: clinical and therapeutical implications", Anvers, Belgium.

Scheen, A., Henrivaux, P., Jandrain, B., Paolisso, G., & Lefebvre, P. (1987). Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII. Diabetes Care, 10 (5), 567-72. doi:10.2337/diacare.10.5.567
Peer Reviewed verified by ORBi

Scheen, A., Henrivaux, P., Jandrain, B., & Lefebvre, P. (1987). U-100 insulin gives some protection against metabolic deterioration due to CSII interruption. Diabetes Care, 10 (6), 707-11. doi:10.2337/diacare.10.6.707
Peer Reviewed verified by ORBi

Lefebvre, P., Luyckx, A., Krzentowski, G., Jandrain, B., Pirnay, F., Crielaard, J.-M., Mosora, F., Lacroix, M., & Pallikarakis, N. (1986). Utilisation d'une charge orale de glucose donnée avant, pendant ou après un exercice musculaire prolongé. Cahiers de Nutrition et de Diététique, XXI, 129-131.
Peer reviewed

Scheen, A., Castillo, M., Jandrain, B., Krzentowski, G., Henrivaux, P., Luyckx, A. S., & Lefebvre, P. (1984). Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Diabetes Care, 7 (4), 338-42. doi:10.2337/diacare.7.4.338
Peer Reviewed verified by ORBi

Contact ORBi